Literature DB >> 1689897

Second International Workshop on FK 506. A potential breakthrough in immunosuppression: clinical implications. October 31, 1989, Barcelona, Spain. Proceedings.

.   

Abstract

Mesh：

Substances：

Year:  1990        PMID： 1689897

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  13 in total

Review 1.  FK 506 and autoimmune disease: perspective and prospects.

Authors:  A W Thomson; T E Starzl
Journal:  Autoimmunity       Date:  1992       Impact factor: 2.815

2.  Overview of FK506 in transplantation.

Authors:  J J Fung; K Abu-Elmagd; S Todo; R Shapiro; A Tzakis; M Jordan; J Armitage; A Jain; M Alessiani; M Martin
Journal:  Clin Transpl       Date:  1990

Review 3.  FK 506: a novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of Pittsburgh.

Authors:  A W Thomson; P B Carroll; J McCauley; J Woo; K Abu-Elmagd; T E Starzl; D H Van Thiel
Journal:  Springer Semin Immunopathol       Date:  1993

Review 4.  FK506 (tacrolimus), a novel immunosuppressant in organ transplantation: clinical, biomedical, and analytical aspects.

Authors:  P E Wallemacq; R Reding
Journal:  Clin Chem       Date:  1993-11       Impact factor: 8.327

5.  Transplantation.

Authors:  T E Starzl; J J Fung
Journal:  JAMA       Date:  1990-05-16       Impact factor: 56.272

Review 6.  Xenobiotics, chimerism and the induction of tolerance following organ transplantation.

Authors:  C P Delaney; A W Thomson; A J Demetris; T E Starzl
Journal:  Ther Immunol       Date:  1994-06

7.  The influence of FK-506 on the thymus: an immunophenotypic and structural analysis.

Authors:  R G Pugh-Humphreys; C S Ross; A W Thomson
Journal:  Immunology       Date:  1990-07       Impact factor: 7.397

8.  In vivo effect of FK506 on human pancreatic islets.

Authors:  C Ricordi; Y J Zeng; R Alejandro; A Tzakis; R Venkataramanan; J Fung; D Bereiter; D H Mintz; T E Starzl
Journal:  Transplantation       Date:  1991-09       Impact factor: 4.939

9.  The effect of bile duct ligation and bile diversion on FK506 pharmacokinetics in dogs.

Authors:  H Furukawa; O Imventarza; R Venkataramanan; M Suzuki; Y Zhu; V S Warty; J Fung; S Todo; T E Starzl
Journal:  Transplantation       Date:  1992-04       Impact factor: 4.939

Review 10.  FK506 in solid organ transplantation.

Authors:  J J Fung; T E Starzl
Journal:  Ther Drug Monit       Date:  1995-12       Impact factor: 3.681
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.